22-38120888-C-T
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong
The NM_003560.4(PLA2G6):c.1613G>A(p.Arg538His) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R538C) has been classified as Pathogenic.
Frequency
Consequence
NM_003560.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251146Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135810
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461332Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 726988
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74496
ClinVar
Submissions by phenotype
Infantile neuroaxonal dystrophy Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 538 of the PLA2G6 protein (p.Arg538His). This variant is present in population databases (rs535486098, gnomAD 0.006%). This missense change has been observed in individuals with infantile neuroaxonal dystrophy and/or Parkinson disease (PMID: 27146152, 27196560, 32771225). ClinVar contains an entry for this variant (Variation ID: 159739). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PLA2G6 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg538Cys amino acid residue in PLA2G6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16783378, 24252552, 32771225; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27146152, 27196560, 33144682, 32771225) -
Iron accumulation in brain Pathogenic:1
- -
Neurodegeneration with brain iron accumulation 2B Pathogenic:1
The missense variant p.R538H in PLA2G6 (NM_003560.4) has been reported previously in individuals with infantile neuroaxonal dystrophy (INAD) (Megahed et al, 2016; Kapoor et al, 2016). It has been submitted to the ClinVar database as Pathogenic. Another missense affecting the same amino acid has also been reported to be disease causing (Morgan T et al, 2006). The p.R538H variant is observed in 2/30,616 (0.0065%) alleles from individuals of South Asian background in gnomAD Exomes and in 1/978 (0.1022%) alleles from individuals of South Asian background in 1000 Genomes. The p.R538H missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 538 of PLA2G6 is conserved in all mammalian species. The nucleotide c.1613 in PLA2G6 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
PLA2G6-associated neurodegeneration Pathogenic:1
The p.Arg538His variant in PLA2G6 has been reported in 5 individuals with PLA2G6-associated neurodegeneration (PMID: 27196560, 27146152, 33144682, Agarwal_2020, 32771225), segregated with disease in 2 affected relatives from 2 families (Agarwal_2020) and has been identified in 0.007% (2/30616) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs535486098). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 159739) and has been interpreted as pathogenic or likely pathogenic by Genetic Services Laboratory (University of Chicago), Neuberg Supratech Reference Laboratories Pvt Ltd (Neuberg Centre for Genomic Medicine), GeneDx, and Invitae. Of the 5 affected individuals, 4 of those were homozygotes, which increases the likelihood that the p.Arg538His variant is pathogenic (PMID: 27196560, 27146152, 33144682, Agarwal_2020). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The phenotype of an individual homozygous for this variant is highly specific for PLA2G6-associated neurodegeneration based on brain iron accumulation on MRI consistent with disease (PMID: 27196560). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive PLA2G6-associated neurodegeneration. ACMG/AMP Criteria applied: PM2, PM3, PP1, PP4 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at